Chlorphenamine Maleate

This article provides an in-depth look at the use of Chlorphenamine Maleate in various clinical trials. Chlorphenamine Maleate, an antihistamine commonly used to treat allergic reactions, has been studied for its effectiveness in different medical conditions and in combination with other treatments. We’ll explore its applications, dosages, and potential benefits as revealed through these clinical studies.

Table of Contents

What is Chlorphenamine Maleate?

Chlorphenamine Maleate, also known as Chlorpheniramine Maleate, is a medication that belongs to a class of drugs called antihistamines. Antihistamines work by blocking the effects of histamine, a substance your body produces during an allergic reaction[1]. This medication is widely used to treat various allergic conditions and has been in use for many years.

Uses and Conditions Treated

Chlorphenamine Maleate is primarily used to treat the following conditions:

  • Seasonal Allergic Rhinitis: This is commonly known as hay fever. Symptoms include sneezing, runny nose, and itchy eyes[1].
  • Allergic Reactions: It can help manage various types of allergic reactions, including those caused by pollen, dust, or other allergens[2].
  • Symptoms of Common Cold: While not its primary use, it can help relieve some symptoms associated with the common cold, such as sneezing and runny nose.
  • Itching and Skin Reactions: It may be used to relieve itching associated with various skin conditions[3].

How It Works

Chlorphenamine Maleate works by blocking the action of histamine in your body. Histamine is a chemical that your immune system releases when it detects something harmful, like an allergen. This release of histamine causes many of the symptoms associated with allergies, such as sneezing, runny nose, and itchy eyes. By blocking histamine, Chlorphenamine Maleate helps to reduce these symptoms[1].

Formulations and Dosages

Chlorphenamine Maleate comes in various formulations, including:

  • Oral tablets: Usually available in 4 mg doses[1].
  • Liquid syrup: Often used for children, typically in a concentration of 2 mg/5 mL[4].
  • Nasal spray: In some cases, it may be combined with other medications in nasal spray form[5].
  • Extended-release capsules: These provide a longer-lasting effect and may be combined with other medications[6].

The dosage can vary depending on the specific condition being treated, the patient’s age, and the formulation used. Always follow your healthcare provider’s instructions or the guidance on the product label.

Clinical Studies and Effectiveness

Several clinical studies have been conducted to evaluate the effectiveness of Chlorphenamine Maleate:

  • A study examined its onset of action in treating allergic rhinitis, demonstrating its quick effectiveness in providing relief from allergy symptoms[1].
  • Another study investigated its pharmacokinetics (how the drug moves through the body) in children and adolescents, helping to establish appropriate dosing for younger patients[2].
  • Research has also explored its potential in enhancing pain relief when combined with other treatments, such as acupuncture[7].

These studies generally show that Chlorphenamine Maleate is effective in managing allergy symptoms and has a good safety profile when used as directed.

Potential Side Effects

Like all medications, Chlorphenamine Maleate can cause side effects, although not everyone experiences them. Common side effects may include:

  • Drowsiness or sleepiness
  • Dry mouth, nose, or throat
  • Dizziness
  • Blurred vision
  • Difficulty urinating

In clinical trials, the safety of Chlorphenamine Maleate was monitored, with researchers tracking the number of patients experiencing adverse events[1]. If you experience any severe or persistent side effects, contact your healthcare provider.

Special Considerations

There are some important points to consider when using Chlorphenamine Maleate:

  • Drowsiness: This medication can cause drowsiness, so avoid driving or operating machinery until you know how it affects you.
  • Alcohol: Avoid consuming alcohol while taking this medication, as it can increase drowsiness.
  • Children and Elderly: Special dosing considerations may apply for these groups. Always consult with a healthcare provider.
  • Pregnancy and Breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor before using this medication.
  • Other Medications: Inform your doctor about all other medications you’re taking, as Chlorphenamine Maleate can interact with certain drugs.

Remember, while Chlorphenamine Maleate is effective for many people, it’s important to use it as directed and to consult with a healthcare professional if you have any concerns or questions about its use.

Study Focus Dosage Form Key Findings/Objectives
Pharmacokinetics in Children and Adolescents Liquid Examined pharmacokinetic parameters of chlorpheniramine in children and adolescents aged 2 to <18 years
Allergy Relief Onset 4 mg tablet Explored onset of effect of chlorpheniramine maleate in a controlled allergen exposure environment
Electroacupuncture Analgesia Enhancement 2 mg and 4 mg tablets Investigated if low-dose chlorpheniramine could facilitate electroacupuncture analgesia in healthy volunteers
COVID-19 Clinical Recovery 0.4% Nasal Spray Evaluated effectiveness of chlorpheniramine nasal spray in COVID-19 treatment and symptom relief
Bioequivalence Study Extended Release Capsule vs. Oral Suspension Compared bioavailability of chlorpheniramine polistirex/hydrocodone polistirex capsule to oral suspension

Ongoing Clinical Trials on Chlorphenamine Maleate

  • Study of venetoclax, obinutuzumab and zanubrutinib combination therapy in young patients with high-risk Chronic Lymphocytic Leukemia and residual disease

    Recruiting

    1 1 1
    Italy
  • Study on Docetaxel and Carboplatin-Docetaxel Combination for Prostate Cancer Patients Progressing After Olaparib Treatment

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Italy
  • Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Austria Croatia Denmark France Germany Greece +6
  • Study of SAR443579 Infusion for Adults and Children with Relapsed or Refractory Acute Myeloid Leukemia, B-Cell Acute Lymphoblastic Leukemia, HR-MDS, or BPDCN

    Not recruiting

    1 1 1
    France The Netherlands
  • Study of Obinutuzumab for Patients with Primary Membranous Nephropathy Resistant or Intolerant to Rituximab

    Not recruiting

    1 1 1
    Italy

Glossary

  • Antihistamine: A type of medication that reduces or blocks the effects of histamine, a substance in the body that causes allergic symptoms.
  • Pharmacokinetic (PK): The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Bioequivalence: The property of two drug products having the same effect in the body and the same potential for adverse effects.
  • Placebo: A substance with no active therapeutic effect, used as a control in testing new drugs.
  • Nasal Congestion: A stuffy or blocked feeling in the nose due to swollen blood vessels and tissues.
  • Anosmia: The loss of the sense of smell.
  • Dysgeusia: An altered sense of taste.
  • Electroacupuncture (EA): A form of acupuncture where a small electric current is passed between pairs of acupuncture needles.
  • Tachyphylaxis: A rapid decrease in the response to a drug after repeated doses over a short period of time.
  • Anaphylactoid Reaction: A reaction that resembles anaphylaxis (a severe, potentially life-threatening allergic reaction) but is not mediated by an allergic mechanism.

References

  1. https://clinicaltrials.gov/study/NCT02722083
  2. https://clinicaltrials.gov/study/NCT00837837
  3. https://clinicaltrials.gov/study/NCT03332524
  4. https://clinicaltrials.gov/study/NCT03879772
  5. https://clinicaltrials.gov/study/NCT05520944
  6. https://clinicaltrials.gov/study/NCT00853294
  7. https://clinicaltrials.gov/study/NCT03805035